These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4039984)

  • 101. [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
    Goldhirsch A; Joss R; Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1105-9. PubMed ID: 6266800
    [No Abstract]   [Full Text] [Related]  

  • 102. Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.
    Brindley CJ; Antoniw P; Newlands ES; Bagshawe KD
    Cancer Chemother Pharmacol; 1985; 15(1):66-71. PubMed ID: 4039984
    [TBL] [Abstract][Full Text] [Related]  

  • 103. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.
    Newell DR; Eeles RA; Gumbrell LA; Boxall FE; Horwich A; Calvert AH
    Cancer Chemother Pharmacol; 1989; 23(6):367-72. PubMed ID: 2469544
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Pharmacokinetics of etoposide in gestochoriocarcinoma.
    D'Incalci M; Sessa C; Rossi C; Roviaro G; Mangioni C
    Cancer Treat Rep; 1985 Jan; 69(1):69-72. PubMed ID: 2981622
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinoma.
    Newlands ES; Bagshawe KD
    Cancer Chemother Pharmacol; 1982; 7(2-3):211-4. PubMed ID: 7083462
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography.
    Strife RJ; Jardine I; Colvin M
    J Chromatogr; 1980 May; 182(2):211-20. PubMed ID: 7380913
    [TBL] [Abstract][Full Text] [Related]  

  • 109. VP16-213 as a single agent in advanced testicular tumors.
    Fitzharris BM; Kaye SB; Saverymuttu S; Newlands ES; Barrett A; Peckham MJ; McElwain TJ
    Eur J Cancer (1965); 1980 Sep; 16(9):1193-7. PubMed ID: 7227446
    [No Abstract]   [Full Text] [Related]  

  • 110. High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma.
    Farina P; Marzillo G; D'Incalci M
    J Chromatogr; 1981 Jan; 222(1):141-5. PubMed ID: 7217322
    [No Abstract]   [Full Text] [Related]  

  • 111. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
    Allen LM; Tejada F; Okonmah AD; Nordqvist S
    Cancer Chemother Pharmacol; 1982; 7(2-3):151-6. PubMed ID: 7083456
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Pharmacokinetics of VP16-213 given by different administration methods.
    D'Incalci M; Farina P; Sessa C; Mangioni C; Conter V; Masera G; Rocchetti M; Pisoni MB; Piazza E; Beer M; Cavalli F
    Cancer Chemother Pharmacol; 1982; 7(2-3):141-5. PubMed ID: 7083454
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The practical benefits of pharmacokinetics in the use of antineoplastic agents.
    Erlichman C; Donehower RC; Chabner BA
    Cancer Chemother Pharmacol; 1980; 4(3):139-45. PubMed ID: 6994913
    [No Abstract]   [Full Text] [Related]  

  • 114. Pharmacokinetic principles of antineoplastic drug therapy.
    Allen LM
    J Clin Pharmacol; 1983; 23(2-3):71-81. PubMed ID: 6853745
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.
    Hande KR; Wedlund PJ; Noone RM; Wilkinson GR; Greco FA; Wolff SN
    Cancer Res; 1984 Jan; 44(1):379-82. PubMed ID: 6690051
    [TBL] [Abstract][Full Text] [Related]  

  • 116. STRIPE: an interactive computer program for the analysis of drug pharmacokinetics.
    Johnston A; Woollard RC
    J Pharmacol Methods; 1983 May; 9(3):193-9. PubMed ID: 6688279
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors.
    Sinkule JA; Hutson P; Hayes FA; Etcubanas E; Evans W
    Cancer Res; 1984 Jul; 44(7):3109-13. PubMed ID: 6539169
    [TBL] [Abstract][Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.